SAB Biotherapeutics (SABS)
(Delayed Data from NSDQ)
$2.88 USD
+0.18 (6.67%)
Updated Jul 31, 2024 12:22 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/19/24 |
---|---|
Current Quarter | -1.13 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 44.90% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.08 |
Next Year | -3.26 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.93M | NA |
# of Estimates | NA | NA | 3 | NA |
High Estimate | NA | NA | 0.95M | NA |
Low Estimate | NA | NA | 0.90M | NA |
Year ago Sales | 0.09M | 1.27M | 2.24M | 0.93M |
Year over Year Growth Est. | NA | NA | -58.46% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.13 | -1.17 | -4.08 | -3.26 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -1.24 | -1.24 | -4.27 | -1.07 |
High Estimate | -1.02 | -1.09 | -3.89 | -1.07 |
Low Estimate | -1.24 | -1.24 | -4.27 | -5.16 |
Year ago EPS | -1.40 | -1.00 | -7.64 | -4.08 |
Year over Year Growth Est. | 19.29% | -17.00% | 46.60% | 20.10% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.13 | -1.17 | -4.08 | -3.26 |
7 Days Ago | -1.13 | -1.17 | -4.08 | -3.26 |
30 Days Ago | -1.13 | -1.17 | -4.08 | -3.26 |
60 Days Ago | -1.02 | -1.09 | -3.99 | -4.36 |
90 Days Ago | -1.14 | -1.28 | -4.31 | -6.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -1.17 | -4.08 | -3.26 |
Zacks Consensus Estimate | -1.13 | -1.17 | -4.08 | -3.26 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | NA | -1.00 | -1.40 | NA |
Estimate | -0.98 | NA | -1.00 | -1.60 | NA |
Difference | 0.44 | NA | 0.00 | 0.20 | 0.21 |
Surprise | 44.90% | NA | 0.00% | 12.50% | 19.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more